Suzanne Broadgate

Suzanne Broadgate is a Postdoctoral Researcher (Researcher) at the Nuffield Department of Clinical Neuroscience, University of Oxford, and an active member of the United Kingdom Inherited Retinal Disease Consortium. Her work focuses on identifying disease-causing genes for inherited retinal dystrophies using next-generation sequencing techniques applied to patient data from Oxford Eye Hospital.

Her educational background includes:

• BSc (Hons) in Experimental Pathology from the University of Glasgow (final-year research on Six gene family expression in the eye)
• PhD in Genetics from UCL Institute of Ophthalmology

Dr. Broadgate's research centers on ocular genetics with emphasis on inherited retinal diseases, particularly macular dystrophies and diabetic macular oedema. She employs whole exome/genome sequencing to characterize retinal maintenance genes and establish molecular diagnoses, directly linking genetic findings to therapeutic target identification. Her methodology integrates clinical data with advanced genomic analysis to elucidate retinal physiology in health and disease.

Analysis of her publications (2005-2020) reveals a strategic evolution from foundational molecular biology (murine Cds genes, FGFR3 neurodevelopment) to specialized ocular genetics. Recent work demonstrates expertise in genotype-phenotype correlations for BEST1/EYS variants, underrepresentation of diabetic macular oedema in genetic studies, and novel mutation identification in ARL2BP. Key trends include increasing focus on next-generation sequencing applications and translational research connecting genetic diagnoses to therapeutic development.

Dr. Broadgate has not been documented as receiving scientific awards.

As a consortium member, she contributes to large-scale genomic analysis projects without individual grant leadership. Her collaborative work with Oxford Eye Hospital clinicians emphasizes patient-centered molecular diagnostics, though no student mentorship activities are referenced. Current efforts prioritize expanding the genetic understanding of retinal diseases through consortium-driven data sharing.

Her laboratory work centers on next-generation sequencing data analysis within the United Kingdom Inherited Retinal Disease Consortium framework, leveraging institutional resources at Nuffield Department of Clinical Neuroscience for genomic interpretation and target validation.